David Hsiehchen, Radhika Kainthla, Heather Kline, Ellen Siglinsky, Chul Ahn, Hao Zhu. "Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial." Nature Communications, 2025. doi:10.1038/s41467-025-60757-7